1. Introduction {#sec1-ijerph-16-03020}
===============

Acute respiratory tract infection (ARTI) is very common, with most people experiencing at least one episode of ARTI each year \[[@B1-ijerph-16-03020]\]. ARTI includes upper respiratory tract infection (URTI) and lower respiratory tract infection (LRTI). The common cold and influenza are the most common ARTIs globally; the highest rate occurs during the winter months in temperate areas with little seasonal change in tropical regions \[[@B2-ijerph-16-03020]\]. During epidemic months, influenza can affect 20% to 50% of people worldwide \[[@B2-ijerph-16-03020]\]. Bronchitis and pneumonia are the two most common infections of the lower airways, and mortality due to LRTI is high \[[@B3-ijerph-16-03020]\]. In 2015, more than 2.8 million deaths worldwide were due to LRTI; children and the elderly are the most affected groups \[[@B3-ijerph-16-03020]\].

Vitamin D is critical for skeletal health and may play a role in other health outcomes, including infection. Vitamin D status is estimated by measuring the serum concentration of 25-hydroxyvitamin D (25(OH)D); this varies seasonally and the lowest concentration in the winter/spring months coincides with the highest ARTI incidence, suggesting a link between vitamin D and ARTI \[[@B4-ijerph-16-03020]\]. This is supported by laboratory studies demonstrating an important role of vitamin D in the immune system. Vitamin D promotes the elimination of pathogens and suppresses prolonged inflammatory responses \[[@B5-ijerph-16-03020],[@B6-ijerph-16-03020],[@B7-ijerph-16-03020]\]. It enhances the production of antimicrobial peptides such as defensins and cathelicidins, which offer natural protection against microbial pathogens \[[@B8-ijerph-16-03020]\].

Many studies have investigated the link between 25(OH)D serum concentration and ARTI and the effect of vitamin D supplementation on ARTI. Two recent meta-analyses of observational studies considered associations between 25(OH)D concentration and ARTI incidence in children \[[@B9-ijerph-16-03020],[@B10-ijerph-16-03020]\]. One included case-control studies in children aged ≤ 5 years and found higher odds of 25(OH)D deficiency in those with LRTI \[[@B9-ijerph-16-03020]\]. The other found an inverse association between prenatal maternal 25(OH)D concentration and risk of ARTI in the offspring \[[@B10-ijerph-16-03020]\]. The most recent systematic review and meta-analysis including older children and adults was published in 2015 as a conference abstract only---it included 19 observational studies and found a significant inverse association between 25(OH)D concentration and risk of ARTI \[[@B11-ijerph-16-03020]\]. A systematic review of 25 observational studies and 14 randomised-controlled trials (RCTs) was completed in 2013 \[[@B12-ijerph-16-03020]\]. It concluded that there was an inverse association between 25(OH)D concentration and risk of ARTI, but did not include a meta-analysis \[[@B12-ijerph-16-03020]\]. Some observational studies have found an inverse link between 25(OH)D concentration and severity of ARTI, as measured by duration of the illness, hospitalisation and severity index \[[@B13-ijerph-16-03020],[@B14-ijerph-16-03020],[@B15-ijerph-16-03020],[@B16-ijerph-16-03020]\]; however, there has been no meta-analysis of these findings.

Results from RCTs investigating the effect of vitamin D supplementation on ARTI are inconsistent. Two meta-analyses found a significant benefit of vitamin D supplementation on ARTI \[[@B17-ijerph-16-03020],[@B18-ijerph-16-03020]\] while another three did not \[[@B19-ijerph-16-03020],[@B20-ijerph-16-03020],[@B21-ijerph-16-03020]\]. There are indications of a greater protective effect in people with marked vitamin D deficiency \[[@B20-ijerph-16-03020],[@B22-ijerph-16-03020]\], but the trials were unable to indicate an optimal concentration of 25(OH)D. We therefore conducted a systematic review and meta-analysis of observational studies to evaluate the link between serum 25(OH)D concentration and the risk and severity of ARTI in adolescents and adults. Findings from this meta-analysis will provide insights into the influence of vitamin D on ARTI risk and severity, and give an indication of the optimal 25(OH)D concentration for ARTI prevention and management.

2. Materials and Methods {#sec2-ijerph-16-03020}
========================

The study protocol was registered with the PROSPERO International Prospective Register of Systematic Reviews prior to commencement \[[@B23-ijerph-16-03020]\].

2.1. Search and Screening Strategy {#sec2dot1-ijerph-16-03020}
----------------------------------

PubMed and EMBASE databases were searched from their inception until 12th June 2019. Keywords were chosen from the Medical Subject Headings (MeSH) terms in PubMed and explosion (exp) of EMTREE terms in EMBASE. Essentially, we searched for the terms "vitamin d" or "25-hydroxyvitamin D" or "25OHD" or "25(OH)D" or "hypovitaminosis D" in combination with "respiratory tract infection\*" or "respiratory infectio\*" or "respiratory diseas\*" or "pneumonia" or "influenza" or "bronchiolitis" or "common cold". The complete search strategies are shown in the [supplementary material (Supplementary File S1)](#app1-ijerph-16-03020){ref-type="app"}.

All titles, abstracts and full text were independently screened by two investigators, Hai Pham and Aninda Rahman. Any discrepancies were resolved through consultation with Rachel Neale and Mary Waterhouse.

2.2. Inclusion/Exclusion Criteria {#sec2dot2-ijerph-16-03020}
---------------------------------

*Inclusion criteria:* The eligibility criteria were: (1) observational studies including cohort, case-control and cross-sectional studies; (2) published in English; (3) full text available; (4) reported the association between circulating 25(OH)D concentration and ARTI risk or severity; (5) the target population was healthy adults or adolescents aged 12 years and older.

*Exclusion criteria*: Studies investigating the link between 25(OH)D concentration and tuberculosis or chronic lung conditions such as chronic obstructive pulmonary disease and asthma were excluded.

2.3. Definition of Outcome {#sec2dot3-ijerph-16-03020}
--------------------------

*Primary outcome*: The primary outcome was the risk of ARTI, defined as an acute infection of the respiratory tract in either the lower or upper airway or with the location not specified. ARTI was either self-reported via surveys or symptom diaries, or clinically confirmed with or without evidence from X-rays or laboratory tests.

*Secondary outcome:* The secondary outcome was the severity of ARTI, defined according to the duration of the illness, hospitalisation, admission to an intensive care unit, symptom severity score or index, or mortality.

2.4. Quality Assessment {#sec2dot4-ijerph-16-03020}
-----------------------

We used the customised Newcastle-Ottawa scale (NOS) to assess the quality of each study \[[@B24-ijerph-16-03020]\]. The NOS tools are slightly different for each study design but generally include three main categories, namely: (1) selection of participants; (2) control for confounders; and (3) measurement of exposure or outcome ([Supplementary File S2](#app1-ijerph-16-03020){ref-type="app"}).

2.5. Statistical Analysis Methods {#sec2dot5-ijerph-16-03020}
---------------------------------

We used STATA 13 (StataCorp, College Station, Texas, USA) and SAS 9.4 (SAS Institute Inc., Cary, NC, USA) for statistical analyses. We included studies in the meta-analysis that reported either: A measure of association between 25(OH)D concentration and ARTI risk or severity (odds ratio (OR), relative risk (RR), hazard ratio (HR), mean difference (MD)) and their 95% confidence interval (CI) or standard deviation (SD); orSufficient data to derive two by two tables of ARTI risk, comparing the lowest versus the highest 25(OH)D category.

We included the estimate from the most fully adjusted model for each study in the meta-analysis comparing the risk of ARTI in the lowest versus highest 25(OH)D category. When a study reported results using different 25(OH)D thresholds, we used 50 nmol/L as it was the most commonly used threshold. Two studies reported HRs as the measure of association between 25(OH)D concentration and risk of ARTI \[[@B25-ijerph-16-03020],[@B26-ijerph-16-03020]\]; we included these two studies in the meta-analysis, considering the HR as an approximation of the OR. A random-effects model was used to pool the results.

We used a method described by Greenland and Longnecker to estimate trends across categories of exposure to calculate the effect of each 10 nmol/L decrease in 25(OH)D concentration on the risk of ARTI \[[@B27-ijerph-16-03020],[@B28-ijerph-16-03020]\]. This method estimates the covariances between multivariable-adjusted odds ratios using the number of cases in each exposure category. We used variance least-squares regression to compute the trends in two studies in which the number of cases in each exposure category was not reported \[[@B25-ijerph-16-03020],[@B29-ijerph-16-03020]\]. The representative value for each 25(OH)D category was assigned using either the midpoint of the range or by subtracting or adding the half width of the adjacent exposure category for open-ended categories \[[@B30-ijerph-16-03020]\]. We also used fixed effects to fit a restricted cubic spline model with 3 knots to evaluate a potential non-linear dose-response association between 25(OH)D concentration and ARTI risk \[[@B28-ijerph-16-03020]\].

For the overall analysis of severity, we defined a severe ARTI to be one that had a moderate-to-high severity score or resulted in death (no studies based on other severity outcomes were included). We also performed a separate meta-analysis to assess the association between 25(OH)D concentration (lowest versus highest category) and ARTI mortality.

2.6. Assessment of Heterogeneity and Publication Bias {#sec2dot6-ijerph-16-03020}
-----------------------------------------------------

Heterogeneity across studies was assessed using I^2^ statistics. We conducted meta-analyses comparing the risk of ARTI in the highest versus the lowest 25(OH)D category stratified by: (i) infection location if reported (URTI or LRTI); (ii) outcome measurement methods (self-reported or clinically confirmed); (iii) mean 25(OH)D concentration in the study population (\<60 nmol/L or ≥60 nmol/L; cut point chosen to maximize the number of studies included in each subgroup); and (iv) factors considered as confounders (fully adjusted model or crude/non-fully adjusted model) to explore potential sources of heterogeneity. We used funnel plots and the Egger test to test for publication bias.

3. Results {#sec3-ijerph-16-03020}
==========

3.1. Identification and Selection of Studies {#sec3dot1-ijerph-16-03020}
--------------------------------------------

[Figure 1](#ijerph-16-03020-f001){ref-type="fig"} illustrates the study selection process. The PubMed and EMBASE searches yielded a total of 1589 records after removing duplicates. We screened the full text of 33 studies and excluded nine that did not meet the selection criteria. Of the 24 studies included, 10 reported the association between 25(OH)D and the risk of ARTI \[[@B25-ijerph-16-03020],[@B29-ijerph-16-03020],[@B31-ijerph-16-03020],[@B32-ijerph-16-03020],[@B33-ijerph-16-03020],[@B34-ijerph-16-03020],[@B35-ijerph-16-03020],[@B36-ijerph-16-03020],[@B37-ijerph-16-03020],[@B38-ijerph-16-03020]\], eight reported on the severity of ARTI \[[@B14-ijerph-16-03020],[@B16-ijerph-16-03020],[@B39-ijerph-16-03020],[@B40-ijerph-16-03020],[@B41-ijerph-16-03020],[@B42-ijerph-16-03020],[@B43-ijerph-16-03020],[@B44-ijerph-16-03020]\], and six reported on both the risk and severity \[[@B13-ijerph-16-03020],[@B15-ijerph-16-03020],[@B26-ijerph-16-03020],[@B45-ijerph-16-03020],[@B46-ijerph-16-03020],[@B47-ijerph-16-03020]\].

3.2. Study Characteristics {#sec3dot2-ijerph-16-03020}
--------------------------

The characteristics of the included studies are summarised in [Table 1](#ijerph-16-03020-t001){ref-type="table"} and [Table 2](#ijerph-16-03020-t002){ref-type="table"}. There were three case-control studies, 13 cross-sectional studies and eight prospective cohort studies. The relationship between ARTI risk or severity and 25(OH)D status was reported either by categories of exposure or per unit increase in exposure. The cut point for 25(OH)D categories varied across studies; the upper limit of the lowest category ranged from 25 to 95 nmol/L, and the cut point for the highest category ranged from 25 to 120 nmol/L ([Table 1](#ijerph-16-03020-t001){ref-type="table"} and [Table 2](#ijerph-16-03020-t002){ref-type="table"}). Serum 25(OH)D concentration was measured using liquid chromatography-mass spectrometry (LCMS) in four studies and non-chromatography assays in 19 studies. One did not specify which method was used to measure 25(OH)D concentration \[[@B44-ijerph-16-03020]\].

ARTI risk was measured by (i) self-report via survey questionnaire or symptom diaries (n = 10), or (ii) clinical diagnosis with or without confirmation from X-ray or a laboratory test (*n* = 6). ARTI severity was measured using a severity index (*n* = 6) such as CURB or CURB-65 (confusion, uraemia, respiratory rate, low blood pressure, age ≥ 65), pulmonary severity score (PSI), or symptom severity score (SSC); duration of the illness (*n* = 10); admission to hospital or intensive care units (*n* = 4); or mortality (*n* = 6). All 24 studies had a moderate-to-high quality score ([Table S1](#app1-ijerph-16-03020){ref-type="app"}).

3.3. Association between 25(OH)D Concentration and Risk of ARTI {#sec3dot3-ijerph-16-03020}
---------------------------------------------------------------

We included 14 of the 16 studies that assessed the association between 25(OH)D concentration and risk of ARTI in the meta-analysis comparing the risk of ARTI in the lowest versus the highest 25(OH)D category (*N* participants = 78,127) and 10 studies were included in the trend analysis (*N* participants = 69,048). Five studies reported risk of ARTI in at least three categories of 25(OH)D concentration and the number of cases by exposure category; these were included in the evaluation of whether there is a non-linear relationship between ARTI risk and 25(OH)D concentration (*N* participants = 37,902).

There was a significantly higher risk of ARTI in the lowest compared with the highest 25(OH)D category (pooled OR 1.83; 95% CI 1.42--2.37; I^2^ = 78.8%; *p* \< 0.001) ([Figure 2](#ijerph-16-03020-f002){ref-type="fig"}). The pooled OR per 10 nmol/L decrease in 25(OH)D was 1.02 (95% CI 0.97--1.07; I^2^ = 72.7%; *p* \< 0.001) ([Figure 3](#ijerph-16-03020-f003){ref-type="fig"}). There was a significant non-linear relationship (*p* for non-linearity = 0.029) with inflexion points at 60 nmol/L and 37.5 nmol/L. The steepest increased risk occurred below 37.5 nmol/L ([Figure 4](#ijerph-16-03020-f004){ref-type="fig"}). Although both linear and spline models were significant, the spline model fitted the data better.

3.4. Association between 25(OH)D Concentration and Severity of ARTI {#sec3dot4-ijerph-16-03020}
-------------------------------------------------------------------

Five studies (*N* participants = 1495) were included in the meta-analysis of the odds of severe ARTI or mortality combined, comparing the highest and the lowest 25(OH)D category and four studies (*N* participants = 1422) were included in the mortality meta-analysis. The pooled ORs for severity/mortality combined and mortality separately were 2.46 (95% CI 1.65--3.66; I^2^ = 49.8%; *p* = 0.093) and 3.00 (95% CI 1.89--4.78; I^2^ = 66.7%; *p* = 0.029), respectively ([Figure 5](#ijerph-16-03020-f005){ref-type="fig"}). The duration of ARTI was also inversely associated with 25(OH)D concentration; low 25(OH)D concentration was associated with a more prolonged ARTI in 7 out of 10 studies ([Table 3](#ijerph-16-03020-t003){ref-type="table"}).

3.5. Studies Excluded from the Meta-Analysis {#sec3dot5-ijerph-16-03020}
--------------------------------------------

Two studies were excluded from the meta-analysis of ARTI risk, and nine studies were excluded from the meta-analysis of ARTI severity. Reasons for exclusion and the main findings of the excluded studies are provided in [Table S2](#app1-ijerph-16-03020){ref-type="app"}. Studies that reported mean (SD) or median (interquartile range (IQR)) of 25(OH)D concentration in people with severe versus non-severe ARTI or mean (SD) severity score by 25(OH)D category were excluded. As different scales were used to measure ARTI severity across studies, we could not pool the mean difference in severity score between the highest and the lowest 25(OH)D category. Overall, results from 6/9 excluded studies showed an inverse association between 25(OH)D concentration and severity of ARTI measured by duration of the illness, severity score, or the number of days absent from duty ([Table S2](#app1-ijerph-16-03020){ref-type="app"}).

3.6. Subgroup Analysis and Publication Bias {#sec3dot6-ijerph-16-03020}
-------------------------------------------

We found evidence of significant heterogeneity (I^2^ = 78.8%, *p* \< 0.001); therefore, we conducted stratified meta-analyses to explore potential sources of heterogeneity ([Figure 6](#ijerph-16-03020-f006){ref-type="fig"}A--D). The association between 25(OH)D concentration and LRTI was stronger than for URTI, but the former had significant heterogeneity ([Figure 6](#ijerph-16-03020-f006){ref-type="fig"}A). Similarly, the association was stronger for studies with mean 25(OH)D concentration \< 60 nmol/L than in those with mean 25(OH)D concentration ≥ 60 nmol/L, but again with significant heterogeneity ([Figure 6](#ijerph-16-03020-f006){ref-type="fig"}C). There was only a small difference in the pooled OR between studies that used a fully adjusted model and those that reported estimates from crude models or those with less complete adjustment, but the latter had significant heterogeneity (I^2^ = 87.2%, *p* \< 0.001) ([Figure 6](#ijerph-16-03020-f006){ref-type="fig"}D).

The funnel plot shows evidence of significant publication bias (*p* = 0.024) ([Figure 7](#ijerph-16-03020-f007){ref-type="fig"}), suggesting that studies with small sample size and insignificant findings were not published.

4. Discussion {#sec4-ijerph-16-03020}
=============

In this systematic review and meta-analysis, we observed significant associations between 25(OH)D concentration and both risk and severity of ARTI, but with significant heterogeneity and evidence of publication bias. There was a non-linear association between 25(OH)D concentration and risk of ARTI, with evidence of a more marked increased risk for 25(OH)D concentration below 37.5 nmol/L.

Findings from our meta-analysis of ARTI risk, which includes the largest number of participants, are consistent with results from previous reports. A meta-analysis published in 2015 as an abstract (*n* = 44,301) reported an increased risk of ARTI in those with 25(OH)D \< 50 nmol/l compared with those ≥ 50 nmol/L. The odds ratio was higher than we found (2.63 vs. 1.83); their analysis included children as well as adults and they did not present an estimate for adults and adolescents only \[[@B11-ijerph-16-03020]\]. A systematic review including 25 observational studies (10 in adults) reported significant inverse association between 25(OH)D concentration and risk of ARTI, but no formal meta-analysis was conducted \[[@B12-ijerph-16-03020]\]. The link between 25(OH)D concentration and risk of ARTI was also reported separately for children and LRTI; a meta-analysis showed a higher prevalence of vitamin D deficiency (\< 50 nmol/L) in children with LRTI (*n* = 550) \[[@B9-ijerph-16-03020]\].

This is the first study to our knowledge which performed a meta-analysis of the association between 25(OH)D concentration and severity of ARTI. We found a stronger association between 25(OH)D concentration and severity of ARTI than with risk of ARTI (OR 2.46 vs. 1.83). The result accords with findings from a systematic review that highlighted the potential link between vitamin D deficiency and severe LRTI in children, but no meta-analysis was included \[[@B9-ijerph-16-03020]\]. It is difficult to meta-analyse the association between 25(OH)D concentration and severity of ARTI because of variability across studies with respect to variability in assay methods used to measure serum 25(OH)D; the cut points used to categorise 25(OH)D concentration; the scales used to measure severity; and the measures used to estimate effect. We could only include five studies in the severity meta-analysis so were unable to assess the association within subgroups or investigate a potential non-linear trend.

Results from RCTs are inconsistent. Some trials found that vitamin D supplementation reduced the risk of ARTI \[[@B48-ijerph-16-03020],[@B49-ijerph-16-03020],[@B50-ijerph-16-03020]\] while others did not \[[@B51-ijerph-16-03020],[@B52-ijerph-16-03020],[@B53-ijerph-16-03020],[@B54-ijerph-16-03020]\]. The inconsistency may be due to differences in study design, vitamin D supplement doses and regimens, and different baseline 25(OH)D concentration. The most recent meta-analysis, using individual participant data, found that vitamin D supplementation reduced the risk of ARTI more strongly in people with 25(OH)D concentration \< 25 nmol/L \[[@B22-ijerph-16-03020]\]. Our findings suggest that supplementation may be of most benefit in people with a 25(OH)D concentration ≤ 37.5 nmol/L, with some benefit up to 60 nmol/L, although these values should be considered with caution in light of the different assays and markedly varying cut point used across studies.

We observed high heterogeneity, and this mostly persisted in subgroup analyses. Despite this, the direction of effect was consistent; lower 25(OH)D concentration was associated with increased risk or severity of ARTI. There are indications of publication bias, indicating that small studies that showed no significant association were either not identified or not published. Publication bias has also been observed in meta-analyses of RCTs \[[@B17-ijerph-16-03020],[@B22-ijerph-16-03020]\]. It is thus possible that the benefits of vitamin D for reducing risk or severity of ARTI have been over-estimated.

5. Conclusions {#sec5-ijerph-16-03020}
==============

Our study is the largest to date and to the best of our knowledge, is the first to include a meta-analysis of the association between 25(OH)D concentration and severity of ARTI. Our findings suggest an important role of vitamin D in prevention of ARTI risk and severity, particularly in people with low 25(OH)D concentration. However, it is challenging to identify an optimal 25(OH)D concentration or a concentration below which supplementation would be of benefit due to the lack of consistency in both 25(OH)D assays and reporting across studies. It is important to improve consistency of reporting, as well as assays, to enable the field to move forward.

The following are available online at <https://www.mdpi.com/1660-4601/16/17/3020/s1>, Table S1: Quality assessment based on the Newcastle-Ottawa Scale (NOS); Table S2: Studies excluded from the meta-analysis and main findings; File S1: Search strategies; File S2: The Newcastle-Ottawa Scale.
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Click here for additional data file.
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###### 

Characteristics of studies reporting the association between risk of acute respiratory tract infection and 25(OH)D concentration.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  First Author\                                         Year of Study   Follow-Up Time   Outcome                Participants                              Age (Mean ± SD)/Sex\   Sample Size   Outcome Measurement             Mean (SD)/Median (Q1--Q3) 25(OH)D (nmol/L)   Lowest 25(OH)D Category (nmol/L)   Highest 25(OH)D Category (nmol/L)   25(OH)D Measurement Method
  (Publication Year)                                                                                                                                      (% Female)                                                                                                                                                                               
  ----------------------------------------------------- --------------- ---------------- ---------------------- ----------------------------------------- ---------------------- ------------- ------------------------------- -------------------------------------------- ---------------------------------- ----------------------------------- ------------------------------------
  **Case-Control Studies**                                                                                                                                                                                                                                                                                                                         

  Jovanovich, A. J. (2014) \[[@B32-ijerph-16-03020]\]   2008--2010                       Pneumonia              Cases: patients with CAP\                 Age: 60 ± 17\          132           Laboratory or x-ray confirmed   Cases: 70.1 (62.2--79.6)\                    50                                 ≥50                                 INCSTAR RIA
                                                                                                                Controls: patients without CAP            Sex: 71% F                                                           Controls: 79.3 (71.1--88.1)                                                                                         

  Nanri, A. (2017) \[[@B35-ijerph-16-03020]\]           2011                             Influenza              Cases: employees with influenza\          Age: 38 ± 12\          532           Self-reported\                  Cases: 56.1 (12.8) Controls: 55.9 (13.0)     50                                 ≥75                                 CBP assay
                                                                                                                Controls: employees without influenza     Sex: 17% F                           (past 6 months)                                                                                                                                     

  Mamani, M. (2017) \[[@B45-ijerph-16-03020]\]          NA                               Pneumonia              Cases: patients with CAP\                 Age: \>18\             149           Laboratory or x-ray confirmed   Cases: 54.7 (61.9) Controls: 48.1 (27.8)     25                                 \>50                                Diarosin CLIA
                                                                                                                Controls: patients' companions            Sex: 30% F                                                                                                                                                                               

  **Cross-Sectional Studies**                                                                                                                                                                                                                                                                                                                      

  Ginde, A.A. (2009) \[[@B29-ijerph-16-03020]\]         1988--1994                       URTI                   NHANES III (1988--1994)                   Age: ≥12\              18,883        Self-reported\                  72.2 (52.3--92.1)                            25                                 ≥75                                 Diasorin RIA
                                                                                                                                                          Sex: 53% F                           (past few days)                                                                                                                                     

  Quraishi, S.A. (2013) \[[@B37-ijerph-16-03020]\]      1988--1994                       Pneumonia              NHANES III (1988--1994)                   Age: ≥17\              16,975        Self-reported\                  59.8 (44.8--79.7)                            25                                 ≥75                                 Diasorin RIA
                                                                                                                                                          Sex: 53% F                           (past 12 months)                                                                                                                                    

  Khalid, A.N. (2015) \[[@B33-ijerph-16-03020]\]        2001--2006                       Acute rhinosinusitis   NHANES\                                   Age: ≥17\              3921          Self-reported\                  54.8 (39.8--69.7)                            50                                 ≥50                                 Diasorin RIA
                                                                                                                2001--2006                                Sex: 51% F                           (past 24 h)                                                                                                                                         

  Monlezun, D.J. (2015) \[[@B34-ijerph-16-03020]\]      2001--2006                       ARTI                   NHANES 2001--2006                         Age: ≥17\              14,108        Self-reported\                  52.3 (37.4--67.2)                            25                                 ≥75                                 Diasorin RIA
                                                                                                                                                          Sex: 51% F                           (past 1 month)                                                                                                                                      

  Berry, D.J. (2011) \[[@B31-ijerph-16-03020]\]         2002--2004                       ARTI                   Birth cohort born 1958                    Age: 45\               6789          Self-reported\                  52.2                                         25                                 ≥100                                IDS OCTEIA
                                                                                                                                                          Sex: 50% F                           (past 3 weeks)                                                                                                                                      

  Robertsen, S. (2014) \[[@B46-ijerph-16-03020]\]       2007--2008                       ARTI                   Tromsø population-based study             Age: ≥40\              6350          Self-reported\                                                               NA                                 NA                                  Roche CLIA
                                                                                                                                                          Sex: 57% F                           (past 7 days)                                                                                                                                       

  Rafiq, R. (2018) \[[@B38-ijerph-16-03020]\]           2008--2012                       Common cold            NEO study, BMI ≥ 27 kg/m^2^               Age: 45--65\           6138          Self-reported\                  71.3                                         50                                 ≥75                                 Diasorin RIA, IDS CLIA, Roche CLIA
                                                                                                                                                          Sex: 56% F                           (past 1 month)                                                                                                                                      

  Lu, D. (2017) \[[@B13-ijerph-16-03020]\]              2011--2012                       Pneumonia              Hospitalised patients                     Age: 60--94\           163           Clinically diagnosed            30.0 (11.2)                                  25                                 ≥25                                 IDS ELISA
                                                                                                                                                          Sex: 31% F                                                                                                                                                                               

  Scullion, L. (2018) \[[@B47-ijerph-16-03020]\]        NA                               ARTI                   Elite rugby players and rowers            Age: 23 ± 3\           54            Self-reported\                  Summer\                                      NA                                 NA                                  Crystal Chem enzymatic assay
                                                                                                                                                          Sex: 25% F                           (past 6 months)                 108.9 (102.8--115.4)\                                                                                               
                                                                                                                                                                                                                               Winter\                                                                                                             
                                                                                                                                                                                                                               86.8 (81.8--92.1)                                                                                                   

  **Prospective Cohort Studies**                                                                                                                                                                                                                                                                                                                   

  Aregbesola, A. (2013) \[[@B25-ijerph-16-03020]\]      1998--2011      10 years         Pneumonia              KIHD study: middle age and aging people   Age: 53--73\           1421          Clinically diagnosed            43.5 (17.8)                                  tertile 1: 8.9--33.8               tertile 3: 50.8--112.8              HPLC
                                                                                                                                                          Sex: 49% F                                                                                                                                                                               

  Porojnicu, A. C. (2012) \[[@B36-ijerph-16-03020]\]    2007            winter season    ARTI                   Medical employees from a hospital         Age: 20--57\           105           Laboratory or x-ray confirmed                                                NA                                 NA                                  HPLC
                                                                                                                                                          Sex: 94% F                                                                                                                                                                               

  Sabetta, J.R. (2010) \[[@B26-ijerph-16-03020]\]       2009--2010      5 months         Viral ARTI             Healthy adults                            Age: 20--88\           198           Clinically diagnosed\           71.0 (2.0)                                   95                                 ≥95                                 Diasorin CLIA
                                                                                                                                                          Sex: 57% F                           Laboratory confirmed                                                                                                                                

  He, C-S. (2013) \[[@B15-ijerph-16-03020]\]            2011            4 months         URTI                   Young athletes                            Age: 18--40\           225           Self-reported\                  53.0 (40.0--66.0)                            12--30                             \>120                               HPLC
                                                                                                                                                          Sex: 30% F                           (4 month diaries)                                                                                                                                   
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: ARTI = acute respiratory tract infection; CAP = community acquired pneumonia; CBP = competitive protein binding; KIHD = Kuopio Ischemic Heart Disease Risk Factor; IDS=Immunodiagnostic Systems; RIA=radioimmunoassay; CLIA=chemiluminescence immunoassay; HPLC = high performance liquid chromatography; LRTI = lower respiratory tract infection; MS = mass spectrometry; NA = not available; NEO = Netherlands Epidemiology of Obesity study; NHANES = National Health and Nutrition Examination Survey; URTI = upper respiratory tract infection.
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###### 

Characteristics of studies reporting the association between severity of ARTI and 25(OH)D.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  First Author (Publication Year)                    Year of Study   Follow-Up Time   Outcome                           Participants                                                 Age (Mean ± SD)/Sex\   Sample Size   Severity Measurement                           Mean (SD)/Median (IQR) 25(OH)D (nmol/L)   Lowest 25(OH)D Category (nmol/L)   Highest 25(OH)D Category (nmol/L)   25(OH)D Measure ment Method
                                                                                                                                                                                     (% Female)                                                                                                                                                                                           
  -------------------------------------------------- --------------- ---------------- --------------------------------- ------------------------------------------------------------ ---------------------- ------------- ---------------------------------------------- ----------------------------------------- ---------------------------------- ----------------------------------- ------------------------------
  **Cross-Sectional Studies**                                                                                                                                                                                                                                                                                                                                                             

  Mamani, M. (2017) \[[@B45-ijerph-16-03020]\]       NA                               Pneumonia severity                Hospitalised patients with CAP                               Age: 68 ± 10\          73            CURB-65 \> 2\                                  Severe: 52.8 (77.5)\                      \<25                               ≥75                                 Diasorin CLIA
                                                                                                                                                                                     Sex: 29% F                           \                                              Non-severe: 56.5 (48.0)\                                                                                         
                                                                                                                                                                                                                          ICU admission\                                 Yes: 59.8 (88.4)\                                                                                                
                                                                                                                                                                                                                          \                                              No: 52.8 (47.6)\                                                                                                 
                                                                                                                                                                                                                          Death                                          Yes: 64.6 (91.8)\                                                                                                
                                                                                                                                                                                                                                                                         No: 53.0 (55.4)                                                                                                  

  Pletz, M. W. (2014) \[[@B14-ijerph-16-03020]\]     2002--2008                       Pneumonia severity                Participants with pneumonia                                  Age: ≥18\              300           Hospitalisation                                Severe: 32.0 (19.5)\                      NA                                 NA                                  Diasorin CLIA
                                                                                                                                                                                     Sex: 43% F                                                                          Non-severe: 40.5 (25.0)                                                                                          

  Robertsen, S. (2014) \[[@B46-ijerph-16-03020]\]    2007--2008                       ARTI                              Tromsø population-based study                                Age: ≥40\              791           Duration of the illness                                                                  NA                                 NA                                  Roche CLIA
                                                                                                                                                                                     Sex: % F                                                                                                                                                                                             

  Lu, D. (2017) \[[@B13-ijerph-16-03020]\]           2011                             Pneumonia\                        Patients with pneumonia                                      Age: 60--94\           49            Duration of hospitalisation                                                              \<25                               ≥25                                 IDS ELISA
                                                                                      severity                                                                                       Sex: 31% F                                                                                                                                                                                           

  Kim, H.J. (2015) \[[@B41-ijerph-16-03020]\]        2012--2014                       Pneumonia severity                Hospitalised patients with CAP                               Age: 18--96\           797           28-day all-cause mortality\                                                              \<50                               ≥50                                 CLIA
                                                                                                                                                                                     Sex: 34% F                           Need for mechanical ventilator                                                                                                                                  

  Brance, M. (2018) \[[@B39-ijerph-16-03020]\]       2015--2016                       Pneumonia severity                Hospitalised patients with CAP                               Age: \>18\             167           CURB-65 ≥ 2                                    Severe: 29.0 (18.3)\                      \<25                               \>50                                Siemens CLIA
                                                                                                                                                                                     Sex: 59% F                                                                          Non-severe: 29.8 (18.8)                                                                                          

  Yaghoobi, M.H. (2019) \[[@B44-ijerph-16-03020]\]   2015                             Ventilator-associated pneumonia   Hospitalised patients with ventilator-associated pneumonia   Age: 18--82\           84            Mortality in 28 days\                          Yes: 61.5 (23.7)\                         \<75                               ≥75                                 NA
                                                                                                                                                                                     Sex: 37% F                           \                                              No: 61.9 (20.8)\                                                                                                 
                                                                                                                                                                                                                          Blood culture\                                 Positive: 53.4 (12.3)\                                                                                           
                                                                                                                                                                                                                          \                                              Negative: 62.7 (22.3)                                                                                            
                                                                                                                                                                                                                          Duration of ventilation\                                                                                                                                        
                                                                                                                                                                                                                          SOFA score                                                                                                                                                      

  Scullion, L. (2018) \[[@B47-ijerph-16-03020]\]     NA                               ARTI                              Elite rugby players and rowers                               Age: 23 ± 3\           53            Duration of the illness                        Summer: 4.8 (3.0)\                        NA                                 NA                                  Crystal Chem enzymatic assay
                                                                                                                                                                                     Sex: 25%F                                                                           Winter: 6.9 (4.3)                                                                                                

  **Prospective Cohort Studies**                                                                                                                                                                                                                                                                                                                                                          

  Laaksi, I. (2007) \[[@B16-ijerph-16-03020]\]       2002            6 months         ARTI severity                     Young military men                                           Age: ≥18\              652           Number of days absence from duty due to ARTI                                             \<40                               ≥40                                 IDS OCTEIA
                                                                                                                                                                                     Sex: 0% F                                                                                                                                                                                            

  Remmelts, H.F. (2012) \[[@B43-ijerph-16-03020]\]   2007--2010      30 days          Pneumonia severity                Hospitalised patients with CAP                               Age: ≥18\              272           ICU admission\                                 ICU: 34.9 (23.8--46.3)\                   \<50                               \>75                                Diasorin CLIA
                                                                                                                                                                                     Sex: 44% F                           \                                              No ICU: 48.3 (30.8--68.4)\                                                                                       
                                                                                                                                                                                                                          30-day mortality\                              Yes: 25.8 (19.8--40.1)\                                                                                          
                                                                                                                                                                                                                          \                                              No: 48.8 (32.4--68.9)                                                                                            
                                                                                                                                                                                                                          PSI \> 3                                                                                                                                                        

  Holter, J.C. (2016) \[[@B40-ijerph-16-03020]\]     2008--2014      6 years          Pneumonia severity                Hospitalised patients with CAP                               Age: ≥18\              241           CURB-65 ≥ 3\                                                                             \<30                               ≥50                                 Siemens CLIA
                                                                                                                                                                                     Sex: 49% F                           ICU admission\                                                                                                                                                  
                                                                                                                                                                                                                          Long-term all-cause mortality                                                                                                                                   

  Leow, L. (2011) \[[@B42-ijerph-16-03020]\]         2008            4 months         Pneumonia severity                Hospitalised patients with CAP                               Age: 16--97\           112           30-day mortality                                                                         \<30                               \>50                                Roche CLIA
                                                                                                                                                                                     Sex: NA                                                                                                                                                                                              

  Sabetta, J.R. (2010) \[[@B26-ijerph-16-03020]\]    2009--2010      5 months         Viral ARTI severity               Healthy adults                                               Age: 20--88\           198           Duration of the illness                                                                  \<95                               ≥95                                 Diasorin CLIA
                                                                                                                                                                                     Sex: 57% F                                                                                                                                                                                           

  He, C-S. (2013) \[[@B15-ijerph-16-03020]\]         2011            4 months         URTI severity                     Young athletes                                               Age: 18--40\           103           Duration of the illness\                                                                 12--30                             \>120                               HPLC
                                                                                                                                                                                     Sex: 31% F                           SSC                                                                                                                                                             
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: ARTI = acute respiratory tract infection; CAP = community acquired pneumonia; CURB-65 = confusion, uremia, respiratory rate, low blood pressure, age ≥ 65 years; ICU = intensive care unit; LC = liquid chromatography; LRTI = lower respiratory tract infection; MS = mass spectrometry; NA = not available; PSI = pulmonary severity score; SSC = symptom severity score; URTI = upper respiratory tract infection.
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###### 

Studies reporting duration of illness according to 25(OH)D concentration.

  First Author (Published Year)   Duration of Illness Mean (SD)/Median (IQR) (Days)   *p*-Value     
  ------------------------------- --------------------------------------------------- ------------- -------
  Mamani, M. (2017) ^1^           11.03 (7.5)                                         9.47 (6.1)    
  Lu, D. (2017) ^1^               26.2 (15.6)                                         15.5 (11.1)   0.014
  He, C-S. (2013) ^2^             13 (10--17)                                         5 (5--7)      ≤0.05
  Sabetta, J.R. (2010) ^2^        6 (2--8)                                            6 (2--27)     
  Laaksi, I. (2007) ^3^           4 (2--6)                                            2 (0--4)      0.004
  Kim, H.J. (2015) ^1^            12.5 (15.4)                                         10.3 (11.0)   0.570
  Robertsen, S. (2014) ^2^        14                                                  13            
  Yaghoobi, M.H. (2019) ^4^       13.4 (6.1)                                          13.7 (9.8)    0.880
  Holter, J.C. (2016) ^2^         4 (2--6)                                            5 (3--10)     
  Scullion, L. (2018) ^2,a^       6.9 (4.3)                                           4.8 (3.0)     0.044

Abbreviations: IQR = interquartile range; SD = standard deviation. ^1^ Duration of hospitalisation; ^2^ Duration of symptoms; ^3^ Number of days of absence from duty due to acute respiratory tract infection; ^4^ Duration of mechanical ventilation. ^a^ The study reported duration of the symptoms, comparing winter and summer; the mean 25(OH)D for winter was 86.8 nmol/L and for summer was 108.9 nmol/L.
